1. Hu, Qingjiang, Masuda, Takaaki, Koike, Kensuke, Oki, Eiji, Mimori, Koshi. 2021. Oxysterol binding protein-like 3 (OSBPL3) is a novel driver gene that promotes tumor growth in part through R-Ras/Akt signaling in gastric cancer. In Scientific reports, 11, 19178. doi:10.1038/s41598-021-98485-9. https://pubmed.ncbi.nlm.nih.gov/34584127/
2. Tian, Kunpeng, Ying, Yongling, Huang, Jingjing, Chen, Longjun, Wu, Lichuan. 2023. The expression, immune infiltration, prognosis, and experimental validation of OSBPL family genes in liver cancer. In BMC cancer, 23, 244. doi:10.1186/s12885-023-10713-9. https://pubmed.ncbi.nlm.nih.gov/36918840/
3. Jiao, Hong-Li, Weng, Bin-Shu, Yan, Shan-Shan, Ding, Yan-Qing, Ye, Ya-Ping. 2020. Upregulation of OSBPL3 by HIF1A promotes colorectal cancer progression through activation of RAS signaling pathway. In Cell death & disease, 11, 571. doi:10.1038/s41419-020-02793-3. https://pubmed.ncbi.nlm.nih.gov/32709922/
4. Sun, Qihui, Zhu, Xiaoqi, Zou, Qi, Xie, Keping, Liu, Jia. 2025. OSBPL3 modulates the immunosuppressive microenvironment and predicts therapeutic outcomes in pancreatic cancer. In Biology direct, 20, 5. doi:10.1186/s13062-025-00596-0. https://pubmed.ncbi.nlm.nih.gov/39789613/
智鼠故事 
